Dephosphorylation of Bcl-2 by protein phosphatase 2A results in apoptosis resistance

Cancer Science

Volumn 95, Issue 3, 2004, Pages 266-270

  Simizu, Siro ^a   Tamura, Yuki ^a,b   Osada, Hiroyuki ^a,b  

^a Japan Science and Technology Agency   (Japan)

^b SAITAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN BCL 2; SERINE;

ADULT; APOPTOSIS; ARTICLE; BLOOD CELL; CARCINOGENICITY; CELL FUNCTION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE;

APOPTOSIS; BLOOD CELLS; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 1842866996     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb02214.x     Document Type: Article

References (45)

1. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
2. Chao DT, Korsmeyer SJ. BCL-2 FAMILY: regulators of cell death. Annu Rev Immunol 1998; 16: 395-419.
3. Reed JC. Bcl-2 family proteins. Oncogene 1998; 17: 3225-36.
4. Vander Heiden MG, Thompson CB. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1999; 1: E209-16.
5. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-9.
6. Tsujimoto Y, Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett 2000; 466: 6-10.
7. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-6.
8. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
9. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-7.
10. Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 1995; 92: 4507-11.
11. Haldar S, Chintapalli J, Croce CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 1996; 56: 1253-5.
12. Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997; 57: 229-33.
13. Kondoh M, Usui T, Nishikiori T, Mayumi T, Osada H. Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin. Biochem J 1999; 340: 411-6.
14. Srivastava RK, Sasaki CY, Hardwick JM, Longo DL. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp Med 1999; 190: 253-65.
15. Parsons R. Phosphatases and tumorigenesis. Curr Opin Oncol 1998; 10: 88-91.
16. Schonthal AH. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 2001; 170: 1-13.
17. Francia G, Poulsom R, Hanby AM, Mitchell SD, Williams G, McKee P, Hart IR. Identification by differential display of a protein phosphatase-2A regulatory subunit preferentially expressed in malignant melanoma cells. Int J Cancer 1999; 82: 709-13.
18. 2/M. Mol Cell Biol 1999; 19: 8469-78.
19. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 1998; 18: 3509-17.
20. May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA, Davidson NE. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2α in association with suppression of apoptosis. J Biol Chem 1994; 269: 26865-70.
21. 2/M phases and its role in cell cycle regulation. J Biol Chem 2000; 275: 21661-7.
22. Guan RJ, Moss SF, Arber N, Krajewski S, Reed JC, Holt PR. 30 KDa phosphorylated form of Bcl-2 protein in human colon. Oncogene 1996; 12: 2605-9.
23. Usui T, Marriott G, Inagaki M, Swarup G, Osada H. Protein phosphatase 2A inhibitors, phoslactomycins. Effects on the cytoskeleton in NIH/3T3 cells. J Biochem 1999; 125: 960-5.
24. Sekiyama Y, Palaniappan N, Reynolds KA, Osada H. Biosynthesis of phoslactomycins: cyclohexanecarboxylic acid as the starter unit. Tetrahedron 2003; 59: 7465-71.
25. Shitashige M, Toi M, Yano T, Shibta M, Matsuo Y, Shibasaki F. Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2. J Biochem 2001; 130: 741-8.
26. Simizu S, Ishida K, Wierzba MK, Osada H. Secretion of heparanase protein is regulated by glycosylation in human tumor cell lines. J Biol Chem 2004; 279: 2697-703.
27. Simizu S, Osada H. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines. Nat Cell Biol 2000; 2: 852-4.
28. Simizu S, Imoto M, Masuda N, Takada M, Umezawa K. Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells. Cancer Res 1996; 56: 4978-82.
29. Simizu S, Tanabe K, Tashiro E, Takada M, Umezawa K, Imoto M. Potentiation of paclitaxel cytotoxicity by inostamycin in human small cell lung carcinoma, Ms-1 cells. Jpn J Cancer Res 1998; 89: 970-6.
30. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899-906.
31. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y. Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 1994; 54: 6-8.
32. Kondo E, Yoshino T, Yamadori I, Matsuo Y, Kawasaki N, Minowada J, Akagi T. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol 1994; 145: 330-7.
33. Coustan-Smith E, Kitanaka A, Pui CH, McNinch L, Evans WE, Raimondi SC, Behm FG, Arico M, Campana D. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood 1996; 87: 1140-6.
34. Shibasaki F, Kondo E, Akagi T, McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 1997; 386: 728-31.
35. Simizu S, Shibasaki F, Osada H. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells. Jpn J Cancer Res 2000; 91: 706-14.
36. Walsh AH, Cheng A, Honkanen RE. Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett 1997; 416: 230-4.
37. Kawada M, Amemiya M, Ishizuka M, Takeuchi T. Cytostatin, an inhibitor of cell adhesion to extracellular matrix, selectively inhibits protein phosphatase 2A. Biochim Biophys Acta 1999; 1452: 209-17.
38. Ruvolo PP, Clark W, Mumby M, Gao F, May WS. A functional role for the B56 α-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J Biol Chem 2002; 277: 22847-52.
39. Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2000; 2: 819-25.
40. Ling Y-H, Tornos C, Perez-Soler R. Phosphorylation of Bcl-2 is a market of M phase events and not a determinant of apoptosis. J Biol Chem 1998; 273: 18994-91.
41. Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD, Pietenpol JA. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J Biol Chem 1998; 273: 30777-84.
42. Deng X, Ito T, Carr B, Mumby M, May WS. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J Biol Chem 1998; 273: 34157-63.
43. Ruvolo PP, Deng X, Ito T, Carr BK, May WS. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 1999; 274: 20296-300.
44. Ito T, Deng X, Carr B, May WS. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 1997; 272: 11671-3.
45. Kondoh M, Usui T, Kobayashi S, Tsuchiya K, Nishikawa K, Nishikiori T, Mayumi T, Osada H. Cell cycle arrest and antitumor activity of pironetin and its derivatives. Cancer Lett 1998; 126: 29-32.